Literature DB >> 28242843

Label-free Proteomic Analysis of Exosomes Derived from Inducible Hepatitis B Virus-Replicating HepAD38 Cell Line.

Xiaofang Jia1, Jieliang Chen1, Dominik A Megger2, Xiaonan Zhang1, Maya Kozlowski1, Lijun Zhang1, Zhong Fang1, Jin Li1, Qiaofang Chu1, Min Wu1, Yaming Li1, Barbara Sitek3, Zhenghong Yuan4.   

Abstract

Hepatitis B virus (HBV) infection is a major health problem worldwide. Recent evidence suggests that some viruses can manipulate the infection process by packing specific viral and cellular components into exosomes, small nanometer-sized (30-150 nm) vesicles secreted from various cells. However, the impact of HBV replication on the content of exosomes produced by hepatocytes has not been fully delineated. In this work, an HBV-inducible cell line HepAD38 was used to directly compare changes in the protein content of exosomes secreted from HepAD38 cells with or without HBV replication. Exosomes were isolated from supernantants of HepAD38 cells cultured with or without doxycycline (dox) and their purity was confirmed by transmission electron microscopy (TEM) and Western immunoblotting assays. Ion-intensity based label-free LC-MS/MS quantitation technologies were applied to analyze protein content of exosomes from HBV replicating cells [referred as HepAD38 (dox-)-exo] and from HBV nonreplicating cells [referred as HepAD38 (dox+)-exo]. A total of 1412 exosomal protein groups were identified, among which the abundance of 35 proteins was significantly changed following HBV replication. Strikingly, 5 subunit proteins from the 26S proteasome complex, including PSMC1, PSMC2, PSMD1, PSMD7 and PSMD14 were consistently enhanced in HepAD38 (dox-)-exo. Bioinformatic analysis of differential exosomal proteins confirmed the significant enrichment of components involved in the proteasomal catabolic process. Proteasome activity assays further suggested that HepAD38 (dox-)-exo had enhanced proteolytic activity compared with HepAD38 (dox+)-exo. Furthermore, human peripheral monocytes incubated with HepAD38 (dox-)-exo induced a significantly lower level of IL-6 secretion compared with IL-6 levels from HepAD38 (dox+)-exo. Irreversible inhibition of proteasomal activity within exosomes restored higher production of IL-6 by monocytes, suggesting that transmission of proteasome subunit proteins by HepAD38 (dox-)-exo might modulate the production of pro-inflammatory molecules in the recipient monocytes. These results revealed the composition and potential function of exosomes produced during HBV replication, thus providing a new perspective on the role of exosomes in HBV-host interaction.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28242843      PMCID: PMC5393393          DOI: 10.1074/mcp.M116.063503

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  63 in total

1.  Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells.

Authors:  Tamara Severi; Chunxiao Ying; Joris Robert Vermeesch; David Cassiman; Lieselotte Cnops; Chris Verslype; Johan Fevery; Lutgarde Arckens; Johan Neyts; Jos F van Pelt
Journal:  Mol Cell Biochem       Date:  2006-09-08       Impact factor: 3.396

2.  The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM.

Authors:  Kent S Boles; Winfried Barchet; Tom Diacovo; Marina Cella; Marco Colonna
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

Review 3.  Hepatitis B virus infection.

Authors:  Christian Trépo; Henry L Y Chan; Anna Lok
Journal:  Lancet       Date:  2014-06-18       Impact factor: 79.321

4.  Anti-HSP auto-antibodies enhance HSP-induced pro-inflammatory cytokine production in human monocytic cells via Toll-like receptors.

Authors:  Shin-ichi Yokota; Seiji Minota; Nobuhiro Fujii
Journal:  Int Immunol       Date:  2006-02-15       Impact factor: 4.823

5.  Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes.

Authors:  Javier Conde-Vancells; Eva Rodriguez-Suarez; Nieves Embade; David Gil; Rune Matthiesen; Mikel Valle; Felix Elortza; Shelly C Lu; Jose M Mato; Juan M Falcon-Perez
Journal:  J Proteome Res       Date:  2008-12       Impact factor: 4.466

6.  HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells.

Authors:  Metka Lenassi; Gerard Cagney; Maofu Liao; Tomaz Vaupotic; Koen Bartholomeeusen; Yifan Cheng; Nevan J Krogan; Ana Plemenitas; B Matija Peterlin
Journal:  Traffic       Date:  2010-01       Impact factor: 6.215

7.  ExoCarta 2012: database of exosomal proteins, RNA and lipids.

Authors:  Suresh Mathivanan; Cassie J Fahner; Gavin E Reid; Richard J Simpson
Journal:  Nucleic Acids Res       Date:  2011-10-11       Impact factor: 16.971

Review 8.  The Dual Role of Exosomes in Hepatitis A and C Virus Transmission and Viral Immune Activation.

Authors:  Andrea Longatti
Journal:  Viruses       Date:  2015-12-17       Impact factor: 5.048

9.  Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicity.

Authors:  Eva Rodríguez-Suárez; Esperanza Gonzalez; Chris Hughes; Javier Conde-Vancells; Andrea Rudella; Felix Royo; Laura Palomo; Felix Elortza; Shelly C Lu; Jose M Mato; Johannes P C Vissers; Juan M Falcón-Pérez
Journal:  J Proteomics       Date:  2014-04-18       Impact factor: 4.044

Review 10.  Exosome function: from tumor immunology to pathogen biology.

Authors:  Jeffrey S Schorey; Sanchita Bhatnagar
Journal:  Traffic       Date:  2008-03-06       Impact factor: 6.215

View more
  19 in total

Review 1.  The functional role of exosome in hepatocellular carcinoma.

Authors:  Hongyu Liu; Baoguo Li
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-30       Impact factor: 4.553

2.  The Host-Pathogen Ecosystem Viewed Through the Prism of Proteomics.

Authors:  Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2017-03-10       Impact factor: 5.911

3.  Cancer Cell Derived Small Extracellular Vesicles Contribute to Recipient Cell Metastasis Through Promoting HGF/c-Met Pathway.

Authors:  Zhi Qiao; Yan Zhang; Maolin Ge; Sha Liu; Xiaoteng Jiang; Zhi Shang; Han Liu; Chengxi Cao; Hua Xiao
Journal:  Mol Cell Proteomics       Date:  2019-06-13       Impact factor: 5.911

4.  Global profiling of megalocytivirus-induced proteins in tongue sole (Cynoglossus semilaevis) spleen identifies cellular processes essential to viral infection.

Authors:  Jian Zhang; Li Sun
Journal:  Dev Comp Immunol       Date:  2018-11-11       Impact factor: 3.636

5.  Comprehensive Characterization of Nanosized Extracellular Vesicles from Central and Peripheral Organs : Implications for Preclinical and Clinical Applications.

Authors:  Subhash Chand; Ala Jo; Neetha Nanoth Vellichirammal; Austin Gowen; Chittibabu Guda; Victoria Schaal; Katherine Odegaard; Hakho Lee; Gurudutt Pendyala; Sowmya V Yelamanchili
Journal:  ACS Appl Nano Mater       Date:  2020-08-06

6.  Extracellular vesicles secreted by HBV-infected cells modulate HBV persistence in hydrodynamic HBV transfection mouse model.

Authors:  Masatoshi Kakizaki; Yuichiro Yamamoto; Motoyuki Otsuka; Kouichi Kitamura; Masatoshi Ito; Hideki Derek Kawai; Masamichi Muramatsu; Tatehiro Kagawa; Ai Kotani
Journal:  J Biol Chem       Date:  2020-07-10       Impact factor: 5.157

Review 7.  Exosomes as therapeutic vehicles in liver diseases.

Authors:  Jingyi Ding; Ju Wang; Jiajia Chen
Journal:  Ann Transl Med       Date:  2021-04

Review 8.  Cloaked Viruses and Viral Factors in Cutting Edge Exosome-Based Therapies.

Authors:  Christos Dogrammatzis; Hope Waisner; Maria Kalamvoki
Journal:  Front Cell Dev Biol       Date:  2020-05-26

Review 9.  Biological consequences of structural and functional proteasome diversity.

Authors:  Alexey V Morozov; Vadim L Karpov
Journal:  Heliyon       Date:  2018-11-02

10.  Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata.

Authors:  Margot Zöller; Kun Zhao; Natalia Kutlu; Nathalie Bauer; Jan Provaznik; Thilo Hackert; Martina Schnölzer
Journal:  Front Immunol       Date:  2018-06-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.